difference between dulaglutide and semaglutide Comparative cardiovascular outcomes of to in patients with type 2 diabetes Key drivers of clinical differences

Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies

Calories: 300330 Protein: 2530g GLP-1 Tip: Cocoa-rich flavors feel indulgent without heaviness

Always tell your surgical team you take this medication

Get started In clinical trials of the oral Wegovy (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%17% over ~64 weeks compared with ~2% with placebo

Percentage change in body weight was calculated as (follow-up weight baseline weight)/baseline weight

These improvements align with broader cardiovascular benefits seen in GLP-1RAs and suggest retatrutides potential for reducing atherosclerosis risk